Video

Dr. Veda N. Giri discusses virtual genetics board

Author(s):

Urology Times staff

“[Attendees] will be learning multiple aspects in terms of the genetic evaluation for men with prostate cancer,” says Veda N. Giri, MD.

In this video, Veda N. Giri, MD, discusses an upcoming virtual genetics board on October 27, 2021 at 5 pm EST (https://www.prostategenetics.com/engagement). Giri is a Professor in Medical Oncology and Cancer Biology at Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania.

Related Videos
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Wayne Kuang, MD, answers a question during a Zoom video interview
Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
Business meeting | Image Credit: © Panumas - stock.adobe.com
Related Content
Prostate Gland - (BPH) Benign Prostatic Hyperplasia | Image Credit: © Judith - stock.adobe.com
December 26th 2024

Top 10 BPH articles and videos of 2024

Benjamin P. Saylor
As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.
3d rendered genetic illustration of human dna under microscope created with generative ai technology | Image Credit: © Picture Studio - stock.adobe.com
December 24th 2024

Quiz: CUA guidelines on specimen and timing considerations with genetic testing

Patrick Campbell
Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.
NCCN reaffirms Prolaris’ prognostic value in prostate cancer
December 18th 2024

NCCN reaffirms Prolaris’ prognostic value in prostate cancer

Hannah Clarke
The inclusion of the test is supported by more than 25 studies demonstrating its clinical utility, including 2 studies published earlier this year.
DNA helix | Image Credit: © Siarhei - stock.adobe.com
December 17th 2024

Quiz: What CUA guidelines say about genomic profiling of tumors in prostate cancer

Patrick Campbell
Test your knowledge of this quiz on the Canadian Urological Association's recommendations for genomic profiling of tumors in prostate cancer.
DNA molecules | Image Credit: © vitstudio - stock.adobe.com
December 10th 2024

Quiz: CUA guidelines on germline genetic testing in prostate cancer

Patrick Campbell
Test your knowledge of this quiz on the Canadian Urological Association's recommendations for germline genetic testing in prostate cancer management.
Epigenomic cfDNA may accurately assess PSMA expression, Lu-PSMA response in mCRPC
November 26th 2024

Epigenomic cfDNA may accurately assess PSMA expression, Lu-PSMA response in mCRPC

Hannah Clarke
“Our study highlights the potential of epigenomic profiling from a simple blood draw to provide a real-time, non-invasive readout of PSMA expression that corresponds with treatment response," says Jacob E. Berchuck, MD.
© 2025 MJH Life Sciences

All rights reserved.